Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioTek Offers Service Through Serlabo in France

Published: Friday, January 06, 2012
Last Updated: Friday, January 06, 2012
Bookmark and Share
Serlabo will provide IQ/OQ/PQ, primary training, service, preventative maintenance and service contracts for users of BioTek's microplate instrumentation.

BioTek Instruments has announced a service partnership with Serlabo Technologies in France.

Serlabo Technologies was privately founded in 2002 and is ISO 9001:2000 certified.

In addition to the service agreement with BioTek, Serlabo offers high-quality products and services to private and public sector customers in France.

According to Philippe Vivier, BioTek France Director of Sales, "The service agreement with Serlabo in France will ensure that our BioTek customers continue to receive high quality instrument service with reduced downtime, and also benefit from a local, dedicated service technician."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioTek Continues International Growth with Launch of BioTek France
BioTek France team includes Dr. Dirk Frese, Philippe Vivier, Damien Brechet and Lionel Capelle.
Wednesday, January 25, 2012
BioTek Recognized with 5x5x5 Award Again
BioTek receives the Award at the 9th annual awards ceremony on Thursday, September 15, 2011.
Saturday, September 17, 2011
BioTek Welcomes New Product Specialist to Cover Expanding Brazilian Market
BioTek Instruments, Inc. welcomes Marcus Stolarski to the company as Product Specialist. Marcus is responsible for supporting BioTek's distribution network and customers in Brazil.
Thursday, March 10, 2011
BioTek Instruments Announces Establishment of Korean Office
Managed by Mr. Yunki Kyung, the new direct sales and service organization will focus on growing BioTek's brand and expanding direct service and application support for our growing customer base in South Korea.
Tuesday, March 01, 2011
BioTek Announces New Applications and Business Development Manager in Canada
Dr Charles Amirmansour is responsible for supporting BioTek's technical and new business activities with Fisher Scientific Canada.
Monday, February 28, 2011
BioTek’s Synergy H1 Receives HTRF Certification
The latest addition to the patent-pending Hybrid Microplate Reader family has received HTRF® certification from Cisbio Bioassays.
Thursday, September 23, 2010
BioTek Instruments and Global Cell Solutions Collaborate at LabAutomation2010
Collaborators announce a new poster detailing the use of BioTek’s microplate instrumentation for various cell-based assays.
Friday, January 29, 2010
BioTek Instruments Launches International Web Sites
Company announces the availability of multi-lingual web sites for international customers.
Thursday, July 30, 2009
Introducing Scientifically Speaking - A Microplate Instrumentation Blog by BioTek Scientists
BioTek scientists are reaching out to the online community through their new blog providing general expertise for microplate instrumentation.
Thursday, July 16, 2009
BioTek Instruments Introduces new Web Site
The new web site, that soon will be available in multiple languages, has improved technical and application resources for life science and drug discovery markets.
Wednesday, February 25, 2009
DLReady Certification Awarded for Synergy 2 and Synergy HT Multi-Detection Microplate Readers
The DLR Assay System provides quantitation of firefly and Renilla luciferase reporters in transfected cells.
Wednesday, November 08, 2006
BioTek Delivers Support through Interactive Program
Qualified customers are introduced to the Winooski, VT facility with a brief plant tour.
Tuesday, September 12, 2006
Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!